Vor Biopharma's GAAP loss for 2021 was $68.899 million, up 59% from $43.337 million in the previous year.
Vor Biopharma's GAAP loss for 2021 was $68.899 million, up 59% from $43.337 million in the previous year.
Vor Biopharma reports for 2021
Vor Biopharma's GAAP loss for 2021 was $68.899 million, up 59% from $43.337 million in the previous year. Source: 
ir.vorbio.com
ir.vorbio.com News feed
English (US) 